- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| ORTIVUS Aktie jetzt für 0€ handeln | |||||
| 13.01. | The observation status for Ortivus AB is removed | 251 | GlobeNewswire | On December 2, 2025, the shares in Ortivus AB (the "Company") were given observation status with reference to a mandatory public offer from Ponderus Invest AB to the other shareholders in Ortivus... ► Artikel lesen | |
| 13.01. | Ortivus AB: Ortivus informs that Ponderus Invest AB has announced the final outcome of the mandatory cash offer to the shareholders of Ortivus Aktiebolag | 76 | GlobeNewswire (Europe) | Ponderus Invest AB ("Ponderus") announced on 2 December 2025 a mandatory cash offer to the shareholders of Ortivus Aktiebolag ("Ortivus" or the "Company") to transfer all of their shares in Ortivus... ► Artikel lesen | |
| 22.12.25 | Ortivus AB: Ortivus informs that Ponderus Invest AB has announced approval from the Swedish Inspectorate of Strategic Products regarding the mandatory cash offer to the shareholders of Ortivus Aktiebolag | 98 | GlobeNewswire (Europe) | Ponderus Invest AB ("Ponderus") announced on 2 December 2025 a mandatory cash offer to the shareholders of Ortivus Aktiebolag ("Ortivus") to transfer all of their shares in Ortivus to Ponderus for SEK... ► Artikel lesen | |
| 18.12.25 | Ortivus AB: The independent bid committee of Ortivus unanimously recommends that shareholders do not accept the mandatory cash offer submitted by Ponderus Invest AB | 195 | GlobeNewswire (Europe) | The independent bid committee of Ortivus AB (publ) ("Ortivus" or the "Company") unanimously recommends that shareholders of Ortivus do not accept the mandatory cash offer submitted by Ponderus Invest... ► Artikel lesen | |
| 17.12.25 | Ortivus AB: Ortivus welcomes Minni Raij as new CFO | 151 | GlobeNewswire (Europe) | Ortivus is pleased to announce the appointment of Minni Raij as the new Chief Financial Officer (CFO) at Ortivus. Minni brings more than two decades of experience in finance and management. Minni will... ► Artikel lesen | |
| 02.12.25 | Ortivus AB receives observation status | 92 | GlobeNewswire | Today, December 2, 2025, Ponderus Invest AB disclosed a mandatory public offer to the other shareholders in Ortivus AB.
The rules of Nasdaq First North Growth Market state that an issuer may... ► Artikel lesen | |
| 02.12.25 | Ortivus AB: Ortivus announces mandatory public offer from Ponderus Invest AB | 104 | GlobeNewswire (Europe) | On 14 November 2025, Ponderus Invest AB announced its intention to return no later than 3 December 2025 with information regarding a potential mandatory public offer to the shareholders of Ortivus AB... ► Artikel lesen | |
| 28.11.25 | Ortivus AB: Interim Report for Ortivus AB (publ) for the period July - September 2025 | 244 | GlobeNewswire (Europe) | "The increased interest we are witnessing in the market and from existing customers, together with the high pace of our product development, gives us a positive outlook for the future."
July-September... ► Artikel lesen | |
| 14.11.25 | Ortivus AB: Ortivus Informs About A Possible Mandatory Bid From Ponderus Invest | 125 | GlobeNewswire (Europe) | Ortivus Aktiebolag ("Ortivus" or the "Company") resolved at an extraordinary general meeting on September 19, 2025 to carry out a fully guaranteed rights issue of B shares corresponding to an issue... ► Artikel lesen | |
| 15.10.25 | Ortivus AB: Ortivus announces that CFO Johan Wewel has decided to leave his position | 123 | GlobeNewswire (Europe) | Ortivus announces today that the company's CFO, Johan Wewel, has decided to leave his position to take up a role outside the Group. Johan Wewel will remain in his current position until 7 January 2026... ► Artikel lesen | |
| 30.09.25 | Ortivus AB: Ortivus publishes information document regarding Rights Issue of shares | 110 | GlobeNewswire (Europe) | THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 19.09.25 | Ortivus AB: Press release from the Extraordinary General Meeting of Ortivus AB regarding Rights Issue | 211 | GlobeNewswire (Europe) | At the Extraordinary General Meeting of Ortivus AB (publ), held in Danderyd on 19 September 2025, the following resolutions were adopted.
For more detailed information, please refer to the full notice... ► Artikel lesen | |
| 09.09.25 | Ortivus AB: Ortivus announces intended allocation of proceeds from the proposed rights issue following agreement with the main shareholder on a new credit facility | 171 | GlobeNewswire (Europe) | Ortivus announced in a press release on 26 August 2025 that the Board of Directors had resolved to propose to an upcoming Extraordinary General Meeting the implementation of a fully guaranteed rights... ► Artikel lesen | |
| 26.05.25 | Ortivus AB: Ortivus receives two-year contract extension from Northern Ireland Ambulance Service (NIAS) | 432 | GlobeNewswire (Europe) | Ortivus AB announces that the Northern Ireland Ambulance Service (NIAS) has formally exercised its contractual right to extend its current agreement with Ortivus by an additional two (2) years. The... ► Artikel lesen | |
| 08.05.25 | Ortivus AB: Interim Report for Ortivus AB (publ) for the period January - March 2025 | 170 | GlobeNewswire (Europe) | "Our ambition is not only to deliver technology, but to be a strategic partner in the transformation of healthcare."
January - March 2025Net sales decreased by 18% and amounted to SEK 18.1 million (22.1).The... ► Artikel lesen | |
| 14.02.25 | Ortivus AB: Ortivus: Year-end report January-December 2024 | 192 | GlobeNewswire (Europe) | During the year, we have carried out extensive organisational changes and strengthened our team to support our growth journey. Additionally, we have implemented a new business system to improve financial... ► Artikel lesen |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 42,600 | -0,47 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers mit einem Kursziel von 60 Euro auf "Buy" belassen. Der Aktienkurs der Münchner spiegle die mittelfristigen... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,480 | +0,52 % | DAX-Check LIVE: Fresenius Medical Care, Nordex, Puma, Sartorius Vz., Schaeffler, Siltronic im Fokus | Ein kurzzeitiger Ausverkauf bei Gold und Silber hat den DAX zum Wochenstart zunächst belastet. Die Unsicherheit beruhigte sich jedoch im Tagesverlauf, auch unterstützt durch eine Erholung an den US-Märkten.... ► Artikel lesen | |
| FRESENIUS | 49,240 | -0,32 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius mit einem Kursziel von 55 Euro auf "Buy" belassen. Die Bad Homburger seien in Verjüngungskur, und der Markt preise... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 38,360 | 0,00 % | BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 | ||
| HEARTFLOW | 25,970 | -7,71 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 27,340 | -1,23 % | Brenntag, Carl Zeiss Meditec, Evonik, Hypoport, Porsche, TeamViewer: Neue Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 27,400 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,150 | 0,00 % | 6 Analysts Have This To Say About Alignment Healthcare | ||
| GENEDX | 84,08 | 0,00 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PROGYNY | 21,920 | -3,73 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| GERRESHEIMER | 25,160 | +0,08 % | JEFFERIES stuft GERRESHEIMER AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Gerresheimer mit einem Kursziel von 34,10 Euro auf "Buy" belassen. Analyst James Vane-Tempest zählt den Spezialverpackungshersteller... ► Artikel lesen | |
| UNITEDHEALTH | 227,85 | -0,02 % | UnitedHealth: Das sieht gar nicht gut aus | Der enttäuschende Ausblick, den UnitedHealth dem Kapitalmarkt vor Kurzem an die Hand gegeben hat, und maue Aussichten für 2027 hinterlassen weitere Spuren im Aktienkurs des größten US-Krankenversicherers.... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,500 | -2,32 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| HIMS & HERS HEALTH | 19,945 | +0,13 % | Hims & Hers zieht an Novo Nordisk vorbei - Der Aktienkurs legt über 10 Prozent zu! | ||
| CLEARPOINT NEURO | 12,570 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe | SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation... ► Artikel lesen |
Das Unternehmen ORTIVUS AB kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ORTIVUS AB finden Sie auf Wallstreet Online.